

Dr. Mark Goodarzi, MD
Dr. Mark Goodarzi, MD is a diabetes & metabolism endocrinologist in Los Angeles, CA and has over 25 years of experience in the medical field. Dr. Goodarzi has extensive experience in Thyroid Disorders and Osteoporosis & Screening. He graduated from University of California at San Francisco in 1997. He is affiliated with Cedars-Sinai Medical Center. He is accepting new patients.
Cedars-Sinai Endocrinology Program
8723 Alden Dr Ste 290 Los Angeles, CA 90048Make an Appointment
Hospital Highlight
Dr. Goodarzi is affiliated with Cedars-Sinai Medical Center West Hollywood, a highly rated hospital.
At a Glance
- Areas of ExpertiseDr. Goodarzi specializes in the areas of Diabetes, Metabolism & Endocrinology & Internal Medicine. • See board certifications
- Explains Conditions Well
- Practices at Top Hospital
- Hospital Satisfaction

Our customers save an overage of $145 on prescriptions
Experience Check
Search for experience in a specific area
Insurance Check
Search for your insurance carrier and choose your plan type
Dr. Goodarzi's Reviews
Likelihood to recommend Dr. Goodarzi
4.5
5 Star | 88% | 88% |
4 Star | 0% | 0% |
3 Star | 0% | 0% |
2 Star | 0% | 0% |
1 Star | 13% | 13% |
Leave a review
How was your experience with Dr. Goodarzi?Overall Patient Satisfaction
Likelihood of recommending Dr. Goodarzi to family and friends is 4.5 out of 5
About Me
care philosophy
The lab of Mark Goodarzi, MD, PhD, seeks to identify genetic factors underlying conditions related to insulin resistance and the metabolic syndrome, using a population genetic approach. A major focus area is elucidation of the genetic determinants...read morebiography
The lab of Mark Goodarzi, MD, PhD, seeks to identify genetic factors underlying conditions related to insulin resistance and the metabolic syndrome, using a population genetic approach. A major focus area is elucidation of the genetic determinants...read moreEndocrinology, Diabetes & Metabolism
*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
University Of California At San Francisco
Medical School, 1997
Healthgrades receives board action history for physicians and physician assistants. The information displayed here is sourced from independent information providers, such as state board websites, and may not be the most up-to-date information. Healthgrades makes no representations with respect to the accuracy of any information provided here and assumes no responsibility or liability for such information.
Learn more about medical license public record checkEnglish
Spanish
The CREB Coactivator CRTC3 Links Catecholamine Signaling to Energy Balance, 2010-12-16
Discovery and Refinement of Loci Associated with Lipid Levels, 2013-10-06
Sex differences in the late first trimester human placenta transcriptome, 2018-01-15
The Trans-Ancestral Genomic Architecture of Glycemic Traits, 2021-05-31
Diabetes in Chronic Pancreatitis: Risk Factors and Natural History, 2021-09-01
FTOandMC4RGene Variants Are Associated with Obesity in Polycystic Ovary Syndrome, 2011-01-20
Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer, 2017-09-12
Genetics Insights in the Relationship between Type 2 Diabetes and Coronary Heart Disease, 2020-05-21
Methods for estimating insulin resistance from untargeted metabolomics data, 2023-08-09
TYPE 2 DIABETES SUSCEPTIBILITY SNPS ARE NOT ASSOCIATED WITH PCOS, 2011-03-27
Nonhuman primate models of polycystic ovary syndrome, 2013-01-29
LYSINE-SPECIFIC DEMETHYLASE 1: AN EPIGENETIC REGULATOR OF SALT-SENSITIVE HYPERTENSION, 2012-04-26
Association Study of Androgen Signaling Pathway Genes in Polycystic Ovary Syndrome, 2015-10-20
Distinguishing Diabetes Secondary to Pancreatic Diseases from Type 2 Diabetes Mellitus, 2021-09-01
Ancestral diversity improves discovery and fine-mapping of genetic loci for anthropometric traits-The Hispanic/Latino Anthropometry Consortium, 2022-03-11
Replication of Calpain-10 Genetic Association with Carotid Intima-Media Thickness, 2009-01-09
Exome-wide association study of plasma lipids in >300,000 individuals, 2017-10-30
Prediction of pancreatic cancer in diabetes patients with worsening glycemic control, 2021-11-02
Epigenetics in Polycystic Ovary Syndrome: A Pilot Study of Global DNA Methylation, 2009-11-25
Association Study of Four Key Folliculogenesis Genes in Polycystic Ovary Syndrome, 2010-03-12
Precision subclassification of type 2 diabetes: a systematic review, 2023-10-05
Prediction of Pancreatic Cancer in Diabetes Patients with Worsening Glycemic Control, 2021-11-02
Associations of autozygosity with a broad range of human phenotypes, 2019-10-31
General Framework for Meta-analysis of Haplotype Association Tests, 2016-03-08
Pharmacometabolomic signature links simvastatin therapy and insulin resistance, 2016-12-23
The Roles of Gut Microbiome and Plasma Metabolites in the Associations between ABO Blood Groups and Insulin Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES), 2022-08-25
How useful are body mass index and history of diabetes in COVID-19 risk stratification?, 2022-04-07
Whole genome sequence association analysis of fasting glucose and fasting insulin levels in diverse cohorts from the NHLBI TOPMed program, 2022-07-28
Focus on Graves' Disease
Locations
Cedars-Sinai Endocrinology Program
Affiliated Hospitals
- Recipient of 37
hospital awardsAmerica's 100 Best Hospitals Award™ (2025, 2024, 2023)
Top 5% in the nation for consistently delivering clinical quality
View all awardsAmerica's 250 Best Hospitals Award™ (2025, 2024, 2023)
Top 5% in the nation for consistently delivering clinical quality
View all patient feedbackHow patients felt about the care they received at this hospital.
83%Patients said they were given information about recovering at home1% lower than the national average
79%Patients would recommend the hospital to friends and family14% higher than the national average
Compare Providers
Providers shown based on Dr. Goodarzi's location and specialty. Show more Diabetes, Metabolism & Endocrinologists.
Your trust is our top concern. Learn more.
We monitor all reviews to ensure they comply with our guidelines and don’t include personal information, profanity, libel, defamation, harassment, obscenity or fraud.
All reviews are confirmed and audited before publication, and community members have the ability to flag inappropriate content for further review by our team.
Doctors can not pay for good reviews, nor can they pay to have negative reviews removed.
Any reviews that are deemed fraudulent or violate our guidelines will be removed immediately.